京新药业：9月29日召开董事会会议

Company Overview - Jingxin Pharmaceutical (SZ 002020) announced on September 29 that its 18th meeting of the 8th board of directors was held via telephone and fax, where the proposal for the fourth employee stock ownership plan was discussed [1] - As of the report date, Jingxin Pharmaceutical has a market capitalization of 16.9 billion yuan [1] Financial Performance - For the first half of 2025, Jingxin Pharmaceutical's revenue composition is as follows: finished drugs accounted for 58.28%, raw materials accounted for 22.44%, medical devices accounted for 17.32%, and other businesses accounted for 1.95% [1]